AVALON
63.25 SAR
+2.61%
Today
+3.53%
1D
Market is closed
Sun
9:00 AM ~ 2:00 PM
Mon
9:00 AM ~ 2:00 PM
Tue
9:00 AM ~ 2:00 PM
Wed
9:00 AM ~ 2:00 PM
Thu
9:00 AM ~ 2:00 PM
Fri
Closed
Sat
Closed
Information
Name
Avalon Pharma
Currency
SAR
Market Cap
2.14B
Avg Daily Volume
82.15K
52 Week High
75.2 SAR
52 Week Low
53.885715 SAR
Trading Hours
See hours
Business Summary
Middle East Pharmaceutical Industries Company engages in the research, development, manufacture, and marketing of generic medicines and pharmaceutical preparations in the Kingdom of Saudi Arabia and internationally. The company operates through three segments: Private, Public, and Export. Its product portfolio includes dermatological, respiratory, cardiovascular, alimentary and anti-infective, musculoskeletal, genitourinary system, and CNS products. It exports its products. The company has a collaboration with Bio-Thera Solutions, Ltd. to develop BAT2406, a biosimilar of Dupixent (dupilumab), a fully human monoclonal IgG4 antibody that inhibits interleukin-4 (IL-4) and interleukin-13 (IL-13) signaling by specifically binding to the IL-4 receptor subunit (IL-4R), a subunit shared by the IL-4 and IL-13 receptor complexes. The company was formerly known as Middle East Chemical Products Factory Company and changed its name to Middle East Pharmaceutical Industries Company in January 2006. Middle East Pharmaceutical Industries Company was incorporated in 1998 and is headquartered in Riyadh, the Kingdom of Saudi Arabia.
Top News
ADES
+0.36%
ALAKARIA
+4.10%
ALAMAR.OTC
+10.37%
ALHAMMADI.OTC
+1.67%
ALMAWARID.MANPOWER
+2.22%
ALUJAIN
+3.14%
AMAK
+7.27%
ARABIANCENTRES.OTC
+1.38%
ARABIANDRILL.OTC
+2.47%
ARABIANM.OTC
+0.00%
ASTRA.INDUSTRIAL
+1.43%
Avalon.pharma
+3.55%
BUDGET.SAUDI
+2.95%
ELM.OTC
+0.08%
ENTAJ.OTC
+6.82%
FIRSTMIL.OTC
-0.61%
FLYNAS.OTC
+3.05%
JAMJOOMP.OTC
+0.70%
JARIR
+0.54%
LEEJAM.OTC
+0.19%
LUMI
+4.69%
Luberef
+1.40%
MASAR.OTC
+0.92%
MIAHONA.OTC
+3.94%
MOUWASAT.OTC
+1.68%
RETAL.OTC
+3.55%
RIYADHCABLE.OTC
+2.05%
SAL
+4.11%
SASCO
+3.96%
SAUDI.KAYAN
+2.14%
SEERA
-0.43%
SIPCHEM
+0.79%
SNB
+2.61%
SPORTCLUBS.OTC
+3.29%
SULAIMAN.ALHABIB
+2.25%
TADAWULGRP.OTC
+2.28%
TANMIAH.OTC
+3.99%
THEEB.OTC
+2.77%
GIB Capital previews Q3 2026 earnings
Argaam
3w ago
Avalon.pharma
+3.55%
Avalon Pharma licenses drug for Saudi Arabia, other markets
Argaam
3w ago
ADES
+0.36%
ALHAMMADI.OTC
+1.67%
ALMAWARID.MANPOWER
+2.22%
ALUJAIN
+3.14%
ARABIANDRILL.OTC
+2.47%
ASTRA.INDUSTRIAL
+1.43%
Avalon.pharma
+3.55%
BUDGET.SAUDI
+2.95%
ELM.OTC
+0.08%
FLYNAS.OTC
+3.05%
JAMJOOMP.OTC
+0.70%
JARIR
+0.54%
LEEJAM.OTC
+0.19%
LUMI
+4.69%
MOUWASAT.OTC
+1.68%
RIYADHCABLE.OTC
+2.05%
SAL
+4.11%
SAUDI.KAYAN
+2.14%
SEERA
-0.43%
SIPCHEM
+0.79%
SULAIMAN.ALHABIB
+2.25%
TADAWULGRP.OTC
+2.28%
THEEB.OTC
+2.77%
A.OTHAIM.OTC
+0.52%
ADVANCED.OTC
+1.88%
ALBILAD
+2.00%
ALINMA
+1.22%
ALKHORAYEF.OTC
+3.32%
ALMAJED.OTC
+4.04%
ALMUNAJEM
+2.70%
ALRAJHI
+2.36%
ARABIANCEMENT.OTC
-0.67%
ARABIANINTERNET.OTC
+0.61%
BINDAWOOD.OTC
-3.35%
CARE.OTC
+3.19%
CATERING.OTC
+1.89%
CITYCEMENT.OTC
-1.24%
DALLAH.OTC
+2.27%
EPCEMENT.OTC
+0.83%
ETIHAD.ETISALAT
+2.65%
FAKEEHCA.OTC
+0.46%
MAADEN
+4.57%
PERFECTP.OTC
+2.78%
QASSIM.OTC
+0.66%
SABIC
+0.34%
SABIC-AGRI-NUTRIENTS
+0.00%
SAUDI.GERMAN.HEALTH
+3.03%
SAUDICEMENT.OTC
+0.00%
SAUDIHARDWARE.OTC
+2.82%
SAUDIPHARMA.OTC
+0.54%
SGS.OTC
+2.44%
SPCC.OTC
+0.75%
TASNEE
+3.00%
UIHC.OTC
+1.27%
UNITEDELEC.OTC
-0.17%
YANSAB
+2.05%
YCC.OTC
-4.31%
YSCC.OTC
+0.72%
ZAIN.KSA
+1.74%
AlJazira Capital issues Q3 2026 earnings forecasts
Argaam
3w ago
Show more
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
